Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.
Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
30 | 56 | 30 | 30 | 13 | 4 | 7 | 15 | 13 | 20 | 25 | 12 | 35 | 13 | 2 |
Research, Review articles and Editorials |
0 | 6 | 2 | 4 | 1 | 1 | 6 | 14 | 12 | 17 | 25 | 12 | 34 | 7 | 2 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
30 | 50 | 28 | 8 | 2 | 0 | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 35 | 102 | 83 | 47 | 82 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
35 | 55 | 58 | 71 | 61 | 49 | 63 | 48 | 72 | 63 | 23 | 8 | 6 | 0 | 0 |
Journal total citations count | 613 |
Journal impact factor | 2.31 |
Journal 5 years impact factor | 3.74 |
Journal cite score | 4.86 |
Journal h-index | 12 |
Pharmacogenetic considerations in the treatment of Alzheimer's disease
CYP2D6 ir CYP2C19 gen? polimorfizm? ?taka klinikiniam antidepresant? efektyvumui gydant vidutinio sunkumo ir sunki? depresij?
Onkolojik ilaç geli?tirilmesinde yeni nesil dizileme teknolojisine dayal? farmasötik uygulamalar
Conjugar a farmacogenética ea monitorização terapêutica de fármacos: uma estratégia na otimização e individualização da farmacoterapia
Pharmacogenetics Informed Decision Making in Adolescent Psychiatric Treatment: A Clinical
ESTABLISHING THE ROADMAP FOR THE IMPLEMENTATION OF GENOMIC MEDICINE AND PHARMACOGENOMICS IN THE UNITED ARAB EMIRATES
Pharmaceutical applications based on next generation sequencing technology in oncologic drug development
Diabetes Mellitus: Classification, Symptoms and Management: A Review
Pharmacogenomics and Phytochemicals
Pharmacogenomics and Personalized Medicine in Type 2 Diabetes
Pharmacogenomic Advancements For The Management Of Diabetes Mellitus
Personalized medicine: A step forward in dental treatment
Farmakogenetinio tyrimo vertinimas psichiatrijoje: retrospektyvi klinikini? atvej? analiz?
Knowledge, Attitudes, and Perceived Barriers toward Genetic Testing and Pharmacogenomics among Healthcare Workers in the United Arab Emirates: A Cross-Sectional Study
The Pharmaceutical Applications of Next Generation Sequencing in Oncology Drug Designing and Development
Pharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case report
Association between Paraoxonase-1 p. Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population
Clinical relevant polymorphisms affecting clopidogrel pharmacokinetics and pharmacodynamics: Insights from the Puerto Rico Newborn Screening Program
CYP2D6 ir CYP2C19 gen? polimorfizm? ?taka klinikiniam antidepresant? efektyvumui gydant vidutinio sunkumo ir sunki? depresij?
Onkolojik ilaç geli?tirilmesinde yeni nesil dizileme teknolojisine dayal? farmasötik uygulamalar